English

GenMark Diagnostics, Inc.

EDGAR

GNMK Annual report (10-K) · filed 2021-02-25

58 filing records in this dataset, filed from 2010-03-19 to 2021-02-25. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

50.1 million USD

2021 Q3 · USD

Exact inputs and evidence

Revenue: 50080000 USD Source

Operating margin

-4.17%

2021 Q3 · %

Exact inputs and evidence

Operating Income: -2087000 USD Source
Revenue: 50080000 USD Source

Operating cash flow

-537 thousand USD

2021 Q3 · USD

Exact inputs and evidence

Operating Cash Flow: 6134000 USD Source
Operating Cash Flow: 6671000 USD Source

Free cash flow

-10.4 million USD

2021 Q3 · USD

Exact inputs and evidence

Operating Cash Flow: 6134000 USD Source
Operating Cash Flow: 6671000 USD Source
Capital Expenditure: 17776000 USD Source
Capital Expenditure: 7874000 USD Source

Cash and cash equivalents: 40.6 million USD 2020-12-31 Source
Exact value

40572000 USD
Long-term debt including current maturities: 69.1 million USD 2019-12-31 Source
Exact value

69145000 USD
Shares outstanding: 72 million shares 2020-12-31 Source
Exact value

71960000 shares

Reported share-count change

19.43% · 11.7 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

60255000 shares · 2019-12-31· Source
71960000 shares · 2020-12-31· Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2021-02-25.

Financial data available through: 2020-12-31.

Coverage by financial measure

Revenue: 11 of 11 periods available· newest 2020-12-31
Operating income: 11 of 11 periods available· newest 2020-12-31
Net income: 11 of 11 periods available· newest 2020-12-31
Operating cash flow: 11 of 11 periods available· newest 2020-12-31
Capital expenditure: 11 of 11 periods available· newest 2020-12-31
Total assets: 10 of 11 periods available· newest 2020-12-31
Total liabilities: 10 of 11 periods available· newest 2020-12-31
Current assets: 10 of 11 periods available· newest 2020-12-31
Current liabilities: 10 of 11 periods available· newest 2020-12-31
Cash and cash equivalents: 11 of 11 periods available· newest 2020-12-31
Long-term debt including current maturities: 6 of 11 periods available· newest 2019-12-31
Shares outstanding: 10 of 11 periods available· newest 2020-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+94.9%

Prior period

USD 88.02 million

2019-01-01 – 2019-12-31
Current period

USD 171.55 million

2020-01-01 – 2020-12-31

Exact inputs and evidence

171554000 − 88021000 = 83533000 USD

88021000 USD · 2019-01-01 – 2019-12-31
Inspect prior input Prior source
171554000 USD · 2020-01-01 – 2020-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · GenMark Diagnostics, Inc. · 2020-12-31 GenMark Diagnostics, Inc. (edgar:1487371) Year-over-year change in Revenue: 83533000 USD Concept: fundies:Revenue Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T17:14:31Z Snapshot: 4462fefe152a6b52ff9c984984a3a5ded6c7a77de6e1a618200eea0be81b76ca Dimensions: Consolidated View: https://fundies.io/companies/edgar/1487371?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 171554000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1487371/000148737121000096/gnmk-20201231.htm#1068308 Filing: 000148737121000096 Input fundies:Revenue: 88021000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1487371/000148737121000096/gnmk-20201231.htm#1069652 Filing: 000148737121000096
The citation records this snapshot. The page link may show a newer release later.
Net income
+USD 28.71 million

Prior period

−USD 47.35 million

2019-01-01 – 2019-12-31
Current period

−USD 18.64 million

2020-01-01 – 2020-12-31

Exact inputs and evidence

-18644000 − -47350000 = 28706000 USD

-47350000 USD · 2019-01-01 – 2019-12-31
Inspect prior input Prior source
-18644000 USD · 2020-01-01 – 2020-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · GenMark Diagnostics, Inc. · 2020-12-31 GenMark Diagnostics, Inc. (edgar:1487371) Year-over-year change in Net income: 28706000 USD Concept: fundies:NetIncome Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T17:14:31Z Snapshot: 4462fefe152a6b52ff9c984984a3a5ded6c7a77de6e1a618200eea0be81b76ca Dimensions: Consolidated View: https://fundies.io/companies/edgar/1487371?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -18644000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1487371/000148737121000096/gnmk-20201231.htm#908393 Filing: 000148737121000096 Input fundies:NetIncome: -47350000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1487371/000148737121000096/gnmk-20201231.htm#909558 Filing: 000148737121000096
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 41.06 million

Prior period

−USD 34.93 million

2019-01-01 – 2019-12-31
Current period

USD 6.13 million

2020-01-01 – 2020-12-31

Exact inputs and evidence

6134000 − -34926000 = 41060000 USD

-34926000 USD · 2019-01-01 – 2019-12-31
Inspect prior input Prior source
6134000 USD · 2020-01-01 – 2020-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · GenMark Diagnostics, Inc. · 2020-12-31 GenMark Diagnostics, Inc. (edgar:1487371) Year-over-year change in Operating cash flow: 41060000 USD Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T17:14:31Z Snapshot: 4462fefe152a6b52ff9c984984a3a5ded6c7a77de6e1a618200eea0be81b76ca Dimensions: Consolidated View: https://fundies.io/companies/edgar/1487371?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: 6134000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1487371/000148737121000096/gnmk-20201231.htm#957752 Filing: 000148737121000096 Input fundies:OperatingCashFlow: -34926000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1487371/000148737121000096/gnmk-20201231.htm#958795 Filing: 000148737121000096
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+749.7%

Prior period

USD 2.09 million

2019-01-01 – 2019-12-31
Current period

USD 17.78 million

2020-01-01 – 2020-12-31

Exact inputs and evidence

17776000 − 2092000 = 15684000 USD

2092000 USD · 2019-01-01 – 2019-12-31
Inspect prior input Prior source
17776000 USD · 2020-01-01 – 2020-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · GenMark Diagnostics, Inc. · 2020-12-31 GenMark Diagnostics, Inc. (edgar:1487371) Year-over-year change in Capital expenditure: 15684000 USD Concept: fundies:CapitalExpenditure Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T17:14:31Z Snapshot: 4462fefe152a6b52ff9c984984a3a5ded6c7a77de6e1a618200eea0be81b76ca Dimensions: Consolidated View: https://fundies.io/companies/edgar/1487371?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 17776000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1487371/000148737121000096/gnmk-20201231.htm#962204 Filing: 000148737121000096 Input fundies:CapitalExpenditure: 2092000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1487371/000148737121000096/gnmk-20201231.htm#963185 Filing: 000148737121000096
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2021 2020-01-01 – 2020-12-31

Revenue USD 171.55 million 100% of revenue
Cost of revenue USD 103.61 million 60% of revenue
Operating expenses USD 79 million 46% of revenue
Operating income −USD 11.05 million −6.4% of revenue
Tax, interest and other Derived USD 7.59 million 4.4% of revenue
Net income −USD 18.64 million −11% of revenue

Cash

Operating cash flow USD 6.13 million 3.6% of revenue
Capital expenditure USD 17.78 million 10% of revenue
Free cash flow Derived −USD 11.64 million −6.8% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2012 Operating loss: operating costs were 576% of revenue.
2013 Operating loss: operating costs were 207% of revenue.
2014 Operating loss: operating costs were 227% of revenue.
2015 Operating loss: operating costs were 228% of revenue.
2016 Operating loss: operating costs were 205% of revenue.
2017 Operating loss: operating costs were 199% of revenue.
2018 Operating loss: operating costs were 213% of revenue.
2019 Operating loss: operating costs were 168% of revenue.
2020 Operating loss: operating costs were 148% of revenue.
2021 Operating loss: operating costs were 106% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2012 2011-01-01 – 2011-12-31	5009000	28872000 Derived	-23863000	107000 Derived	-23970000	-20590000 Derived	Source 2011-01-01 – 2011-12-31: 5009000 USD Inspect Revenue Open source 2011-01-01 – 2011-12-31: -23863000 USD Inspect Operating Income Open source 2011-01-01 – 2011-12-31: -23970000 USD Inspect Net Income Open source 2011-01-01 – 2011-12-31: -19214000 USD Inspect Operating Cash Flow Open source 2011-01-01 – 2011-12-31: 1376000 USD Inspect Capital Expenditure Open source
2013 2012-01-01 – 2012-12-31	20469000	42360000 Derived	-21891000	212000 Derived	-22103000	-19719000 Derived	Source 2012-01-01 – 2012-12-31: 20469000 USD Inspect Revenue Open source 2012-01-01 – 2012-12-31: -21891000 USD Inspect Operating Income Open source 2012-01-01 – 2012-12-31: -22103000 USD Inspect Net Income Open source 2012-01-01 – 2012-12-31: -16243000 USD Inspect Operating Cash Flow Open source 2012-01-01 – 2012-12-31: 3476000 USD Inspect Capital Expenditure Open source
2014 2013-01-01 – 2013-12-31	27404000	62284000 Derived	-34880000	-1237000 Derived	-33643000	-28066000 Derived	Source 2013-01-01 – 2013-12-31: 27404000 USD Inspect Revenue Open source 2013-01-01 – 2013-12-31: -34880000 USD Inspect Operating Income Open source 2013-01-01 – 2013-12-31: -33643000 USD Inspect Net Income Open source 2013-01-01 – 2013-12-31: -23796000 USD Inspect Operating Cash Flow Open source 2013-01-01 – 2013-12-31: 4270000 USD Inspect Capital Expenditure Open source
2015 2014-01-01 – 2014-12-31	30594000	69648000 Derived	-39054000	-791000 Derived	-38263000	-35298000 Derived	Source 2014-01-01 – 2014-12-31: 30594000 USD Inspect Revenue Open source 2014-01-01 – 2014-12-31: -39054000 USD Inspect Operating Income Open source 2014-01-01 – 2014-12-31: -38263000 USD Inspect Net Income Open source 2014-01-01 – 2014-12-31: -29572000 USD Inspect Operating Cash Flow Open source 2014-01-01 – 2014-12-31: 5726000 USD Inspect Capital Expenditure Open source
2016 2015-01-01 – 2015-12-31	39411000	80946000 Derived	-41535000	662000 Derived	-42197000	-35671000 Derived	Source 2015-01-01 – 2015-12-31: 39411000 USD Inspect Revenue Open source 2015-01-01 – 2015-12-31: -41535000 USD Inspect Operating Income Open source 2015-01-01 – 2015-12-31: -42197000 USD Inspect Net Income Open source 2015-01-01 – 2015-12-31: -31915000 USD Inspect Operating Cash Flow Open source 2015-01-01 – 2015-12-31: 3756000 USD Inspect Capital Expenditure Open source
2017 2016-01-01 – 2016-12-31	49274000	98255000 Derived	-48981000	1620000 Derived	-50601000	-42637000 Derived	Source 2016-01-01 – 2016-12-31: 49274000 USD Inspect Revenue Open source 2016-01-01 – 2016-12-31: -48981000 USD Inspect Operating Income Open source 2016-01-01 – 2016-12-31: -50601000 USD Inspect Net Income Open source 2016-01-01 – 2016-12-31: -35637000 USD Inspect Operating Cash Flow Open source 2016-01-01 – 2016-12-31: 7000000 USD Inspect Capital Expenditure Open source
2018 2017-01-01 – 2017-12-31	52519000	112036000 Derived	-59517000	2333000 Derived	-61850000	-58237000 Derived	Source 2017-01-01 – 2017-12-31: 52519000 USD Inspect Revenue Open source 2017-01-01 – 2017-12-31: -59517000 USD Inspect Operating Income Open source 2017-01-01 – 2017-12-31: -61850000 USD Inspect Net Income Open source 2017-01-01 – 2017-12-31: -53422000 USD Inspect Operating Cash Flow Open source 2017-01-01 – 2017-12-31: 4815000 USD Inspect Capital Expenditure Open source
2019 2018-01-01 – 2018-12-31	70759000	118531000 Derived	-47772000	2728000 Derived	-50500000	-35087000 Derived	Source 2018-01-01 – 2018-12-31: 70759000 USD Inspect Revenue Open source 2018-01-01 – 2018-12-31: -47772000 USD Inspect Operating Income Open source 2018-01-01 – 2018-12-31: -50500000 USD Inspect Net Income Open source 2018-01-01 – 2018-12-31: -32512000 USD Inspect Operating Cash Flow Open source 2018-01-01 – 2018-12-31: 2575000 USD Inspect Capital Expenditure Open source
2020 2019-01-01 – 2019-12-31	88021000	129835000 Derived	-41814000	5536000 Derived	-47350000	-37018000 Derived	Source 2019-01-01 – 2019-12-31: 88021000 USD Inspect Revenue Open source 2019-01-01 – 2019-12-31: -41814000 USD Inspect Operating Income Open source 2019-01-01 – 2019-12-31: -47350000 USD Inspect Net Income Open source 2019-01-01 – 2019-12-31: -34926000 USD Inspect Operating Cash Flow Open source 2019-01-01 – 2019-12-31: 2092000 USD Inspect Capital Expenditure Open source
2021 2020-01-01 – 2020-12-31	171554000	182605000 Derived	-11051000	7593000 Derived	-18644000	-11642000 Derived	Source 2020-01-01 – 2020-12-31: 171554000 USD Inspect Revenue Open source 2020-01-01 – 2020-12-31: -11051000 USD Inspect Operating Income Open source 2020-01-01 – 2020-12-31: -18644000 USD Inspect Net Income Open source 2020-01-01 – 2020-12-31: 6134000 USD Inspect Operating Cash Flow Open source 2020-01-01 – 2020-12-31: 17776000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 171.6M 2021

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20122011-12-31	Revenue	5009000	Revenue: 5009000 Open source
20132012-12-31	Revenue	20469000	Revenue: 20469000 Open source
20142013-12-31	Revenue	27404000	Revenue: 27404000 Open source
20152014-12-31	Revenue	30594000	Revenue: 30594000 Open source
20162015-12-31	Revenue	39411000	Revenue: 39411000 Open source
20172016-12-31	Revenue	49274000	Revenue: 49274000 Open source
20182017-12-31	Revenue	52519000	Revenue: 52519000 Open source
20192018-12-31	Revenue	70759000	Revenue: 70759000 Open source
20202019-12-31	Revenue	88021000	Revenue: 88021000 Open source
20212020-12-31	Revenue	171554000	Revenue: 171554000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

94.9% 2021

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20122011-12-31	Year over year	95.4%	Revenue: 5009000 Open source Revenue: 2564000 Open source
20132012-12-31	Year over year	308.6%	Revenue: 20469000 Open source Revenue: 5009000 Open source
20142013-12-31	Year over year	33.9%	Revenue: 27404000 Open source Revenue: 20469000 Open source
20152014-12-31	Year over year	11.6%	Revenue: 30594000 Open source Revenue: 27404000 Open source
20162015-12-31	Year over year	28.8%	Revenue: 39411000 Open source Revenue: 30594000 Open source
20172016-12-31	Year over year	25%	Revenue: 49274000 Open source Revenue: 39411000 Open source
20182017-12-31	Year over year	6.6%	Revenue: 52519000 Open source Revenue: 49274000 Open source
20192018-12-31	Year over year	34.7%	Revenue: 70759000 Open source Revenue: 52519000 Open source
20202019-12-31	Year over year	24.4%	Revenue: 88021000 Open source Revenue: 70759000 Open source
20212020-12-31	Year over year	94.9%	Revenue: 171554000 Open source Revenue: 88021000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -6.4% 2021

Net margin -10.9% 2021

Free cash flow margin -6.8% 2021

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20122011-12-31	Operating margin	-476.4%	Operating Income: -23863000 Open source Revenue: 5009000 Open source
20132012-12-31	Operating margin	-106.9%	Operating Income: -21891000 Open source Revenue: 20469000 Open source
20142013-12-31	Operating margin	-127.3%	Operating Income: -34880000 Open source Revenue: 27404000 Open source
20152014-12-31	Operating margin	-127.7%	Operating Income: -39054000 Open source Revenue: 30594000 Open source
20162015-12-31	Operating margin	-105.4%	Operating Income: -41535000 Open source Revenue: 39411000 Open source
20172016-12-31	Operating margin	-99.4%	Operating Income: -48981000 Open source Revenue: 49274000 Open source
20182017-12-31	Operating margin	-113.3%	Operating Income: -59517000 Open source Revenue: 52519000 Open source
20192018-12-31	Operating margin	-67.5%	Operating Income: -47772000 Open source Revenue: 70759000 Open source
20202019-12-31	Operating margin	-47.5%	Operating Income: -41814000 Open source Revenue: 88021000 Open source
20212020-12-31	Operating margin	-6.4%	Operating Income: -11051000 Open source Revenue: 171554000 Open source
20122011-12-31	Net margin	-478.5%	Net Income: -23970000 Open source Revenue: 5009000 Open source
20132012-12-31	Net margin	-108%	Net Income: -22103000 Open source Revenue: 20469000 Open source
20142013-12-31	Net margin	-122.8%	Net Income: -33643000 Open source Revenue: 27404000 Open source
20152014-12-31	Net margin	-125.1%	Net Income: -38263000 Open source Revenue: 30594000 Open source
20162015-12-31	Net margin	-107.1%	Net Income: -42197000 Open source Revenue: 39411000 Open source
20172016-12-31	Net margin	-102.7%	Net Income: -50601000 Open source Revenue: 49274000 Open source
20182017-12-31	Net margin	-117.8%	Net Income: -61850000 Open source Revenue: 52519000 Open source
20192018-12-31	Net margin	-71.4%	Net Income: -50500000 Open source Revenue: 70759000 Open source
20202019-12-31	Net margin	-53.8%	Net Income: -47350000 Open source Revenue: 88021000 Open source
20212020-12-31	Net margin	-10.9%	Net Income: -18644000 Open source Revenue: 171554000 Open source
20122011-12-31	Free cash flow margin	-411.1%	Revenue: 5009000 Open source Operating Cash Flow: -19214000 Open source Capital Expenditure: 1376000 Open source
20132012-12-31	Free cash flow margin	-96.3%	Revenue: 20469000 Open source Operating Cash Flow: -16243000 Open source Capital Expenditure: 3476000 Open source
20142013-12-31	Free cash flow margin	-102.4%	Revenue: 27404000 Open source Operating Cash Flow: -23796000 Open source Capital Expenditure: 4270000 Open source
20152014-12-31	Free cash flow margin	-115.4%	Revenue: 30594000 Open source Operating Cash Flow: -29572000 Open source Capital Expenditure: 5726000 Open source
20162015-12-31	Free cash flow margin	-90.5%	Revenue: 39411000 Open source Operating Cash Flow: -31915000 Open source Capital Expenditure: 3756000 Open source
20172016-12-31	Free cash flow margin	-86.5%	Revenue: 49274000 Open source Operating Cash Flow: -35637000 Open source Capital Expenditure: 7000000 Open source
20182017-12-31	Free cash flow margin	-110.9%	Revenue: 52519000 Open source Operating Cash Flow: -53422000 Open source Capital Expenditure: 4815000 Open source
20192018-12-31	Free cash flow margin	-49.6%	Revenue: 70759000 Open source Operating Cash Flow: -32512000 Open source Capital Expenditure: 2575000 Open source
20202019-12-31	Free cash flow margin	-42.1%	Revenue: 88021000 Open source Operating Cash Flow: -34926000 Open source Capital Expenditure: 2092000 Open source
20212020-12-31	Free cash flow margin	-6.8%	Revenue: 171554000 Open source Operating Cash Flow: 6134000 Open source Capital Expenditure: 17776000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD 6.1M 2021

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20122011-12-31	Operating cash flow	-19214000	Operating Cash Flow: -19214000 Open source
20132012-12-31	Operating cash flow	-16243000	Operating Cash Flow: -16243000 Open source
20142013-12-31	Operating cash flow	-23796000	Operating Cash Flow: -23796000 Open source
20152014-12-31	Operating cash flow	-29572000	Operating Cash Flow: -29572000 Open source
20162015-12-31	Operating cash flow	-31915000	Operating Cash Flow: -31915000 Open source
20172016-12-31	Operating cash flow	-35637000	Operating Cash Flow: -35637000 Open source
20182017-12-31	Operating cash flow	-53422000	Operating Cash Flow: -53422000 Open source
20192018-12-31	Operating cash flow	-32512000	Operating Cash Flow: -32512000 Open source
20202019-12-31	Operating cash flow	-34926000	Operating Cash Flow: -34926000 Open source
20212020-12-31	Operating cash flow	6134000	Operating Cash Flow: 6134000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -11.6M 2021

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20122011-12-31	Free cash flow	-20590000	Operating Cash Flow: -19214000 Open source Capital Expenditure: 1376000 Open source
20132012-12-31	Free cash flow	-19719000	Operating Cash Flow: -16243000 Open source Capital Expenditure: 3476000 Open source
20142013-12-31	Free cash flow	-28066000	Operating Cash Flow: -23796000 Open source Capital Expenditure: 4270000 Open source
20152014-12-31	Free cash flow	-35298000	Operating Cash Flow: -29572000 Open source Capital Expenditure: 5726000 Open source
20162015-12-31	Free cash flow	-35671000	Operating Cash Flow: -31915000 Open source Capital Expenditure: 3756000 Open source
20172016-12-31	Free cash flow	-42637000	Operating Cash Flow: -35637000 Open source Capital Expenditure: 7000000 Open source
20182017-12-31	Free cash flow	-58237000	Operating Cash Flow: -53422000 Open source Capital Expenditure: 4815000 Open source
20192018-12-31	Free cash flow	-35087000	Operating Cash Flow: -32512000 Open source Capital Expenditure: 2575000 Open source
20202019-12-31	Free cash flow	-37018000	Operating Cash Flow: -34926000 Open source Capital Expenditure: 2092000 Open source
20212020-12-31	Free cash flow	-11642000	Operating Cash Flow: 6134000 Open source Capital Expenditure: 17776000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

57.9% 2021

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20122011-12-31	Liabilities / assets	19.8%	Total Liabilities: 7552000 Open source Total Assets: 38186000 Open source
20132012-12-31	Liabilities / assets	17%	Total Liabilities: 11566000 Open source Total Assets: 68016000 Open source
20142013-12-31	Liabilities / assets	15.2%	Total Liabilities: 13946000 Open source Total Assets: 91970000 Open source
20152014-12-31	Liabilities / assets	15.2%	Total Liabilities: 13946000 Open source Total Assets: 91970000 Open source
20162015-12-31	Liabilities / assets	31.2%	Total Liabilities: 22070000 Open source Total Assets: 70667000 Open source
20172016-12-31	Liabilities / assets	52.5%	Total Liabilities: 42173000 Open source Total Assets: 80324000 Open source
20182017-12-31	Liabilities / assets	41.8%	Total Liabilities: 51142000 Open source Total Assets: 122299000 Open source
20192018-12-31	Liabilities / assets	63.9%	Total Liabilities: 59434000 Open source Total Assets: 92981000 Open source
20202019-12-31	Liabilities / assets	89.1%	Total Liabilities: 99310000 Open source Total Assets: 111473000 Open source
20212020-12-31	Liabilities / assets	57.9%	Total Liabilities: 129336000 Open source Total Assets: 223534000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

3.92× 2021

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20122011-12-31	Current assets / current liabilities	5.31×	Current Assets: 33908000 Open source Current Liabilities: 6381000 Open source
20132012-12-31	Current assets / current liabilities	6.32×	Current Assets: 58002000 Open source Current Liabilities: 9174000 Open source
20142013-12-31	Current assets / current liabilities	6.35×	Current Assets: 78107000 Open source Current Liabilities: 12293000 Open source
20152014-12-31	Current assets / current liabilities	6.35×	Current Assets: 78107000 Open source Current Liabilities: 12293000 Open source
20162015-12-31	Current assets / current liabilities	5.28×	Current Assets: 55957000 Open source Current Liabilities: 10589000 Open source
20172016-12-31	Current assets / current liabilities	2.21×	Current Assets: 58449000 Open source Current Liabilities: 26421000 Open source
20182017-12-31	Current assets / current liabilities	3.45×	Current Assets: 95831000 Open source Current Liabilities: 27743000 Open source
20192018-12-31	Current assets / current liabilities	3.37×	Current Assets: 68429000 Open source Current Liabilities: 20287000 Open source
20202019-12-31	Current assets / current liabilities	3.43×	Current Assets: 83397000 Open source Current Liabilities: 24316000 Open source
20212020-12-31	Current assets / current liabilities	3.92×	Current Assets: 172962000 Open source Current Liabilities: 44130000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2012 2011-01-01 – 2011-12-31	−USD 23.97 million Exact value Exact value: -23970000 USD 2011-01-01 – 2011-12-31: -23970000 USD Inspect Net Income Open source Share or cite Citation for Net Income · GenMark Diagnostics, Inc. · 2011-12-31 GenMark Diagnostics, Inc. (edgar:1487371) Net Income: -23970000 USD Concept: fundies:NetIncome Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T17:14:31Z Snapshot: 4462fefe152a6b52ff9c984984a3a5ded6c7a77de6e1a618200eea0be81b76ca Dimensions: Consolidated View: https://fundies.io/companies/edgar/1487371/explain?concept=fundies%3ANetIncome&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:NetIncome: -23970000 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1487371/000144530514000991/na-20131231.xml#701926 Filing: 000144530514000991 The citation records this snapshot. The page link may show a newer release later.	−USD 19.21 million Exact value Exact value: -19214000 USD 2011-01-01 – 2011-12-31: -19214000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · GenMark Diagnostics, Inc. · 2011-12-31 GenMark Diagnostics, Inc. (edgar:1487371) Operating Cash Flow: -19214000 USD Concept: fundies:OperatingCashFlow Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T17:14:31Z Snapshot: 4462fefe152a6b52ff9c984984a3a5ded6c7a77de6e1a618200eea0be81b76ca Dimensions: Consolidated View: https://fundies.io/companies/edgar/1487371/explain?concept=fundies%3AOperatingCashFlow&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -19214000 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1487371/000144530514000991/na-20131231.xml#701404 Filing: 000144530514000991 The citation records this snapshot. The page link may show a newer release later.	USD 1.38 million Exact value Exact value: 1376000 USD 2011-01-01 – 2011-12-31: 1376000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · GenMark Diagnostics, Inc. · 2011-12-31 GenMark Diagnostics, Inc. (edgar:1487371) Capital Expenditure: 1376000 USD Concept: fundies:CapitalExpenditure Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T17:14:31Z Snapshot: 4462fefe152a6b52ff9c984984a3a5ded6c7a77de6e1a618200eea0be81b76ca Dimensions: Consolidated View: https://fundies.io/companies/edgar/1487371/explain?concept=fundies%3ACapitalExpenditure&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1376000 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1487371/000144530514000991/na-20131231.xml#747639 Filing: 000144530514000991 The citation records this snapshot. The page link may show a newer release later.	−USD 20.59 million Calculation and evidence -19214000 − 1376000 USD Exact free cash flow: -20590000 USD 2011-01-01 – 2011-12-31: -19214000 USD · Inspect Operating Cash Flow · Source 2011-01-01 – 2011-12-31: 1376000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · GenMark Diagnostics, Inc. · 2011-12-31 GenMark Diagnostics, Inc. (edgar:1487371) Free cash flow: -20590000 USD Concept: free-cash-flow Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T17:14:31Z Snapshot: 4462fefe152a6b52ff9c984984a3a5ded6c7a77de6e1a618200eea0be81b76ca Dimensions: Consolidated View: https://fundies.io/companies/edgar/1487371?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -19214000 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1487371/000144530514000991/na-20131231.xml#701404 Filing: 000144530514000991 Input fundies:CapitalExpenditure: 1376000 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1487371/000144530514000991/na-20131231.xml#747639 Filing: 000144530514000991 The citation records this snapshot. The page link may show a newer release later.
2013 2012-01-01 – 2012-12-31	−USD 22.1 million Exact value Exact value: -22103000 USD 2012-01-01 – 2012-12-31: -22103000 USD Inspect Net Income Open source Share or cite Citation for Net Income · GenMark Diagnostics, Inc. · 2012-12-31 GenMark Diagnostics, Inc. (edgar:1487371) Net Income: -22103000 USD Concept: fundies:NetIncome Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T17:14:31Z Snapshot: 4462fefe152a6b52ff9c984984a3a5ded6c7a77de6e1a618200eea0be81b76ca Dimensions: Consolidated View: https://fundies.io/companies/edgar/1487371/explain?concept=fundies%3ANetIncome&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:NetIncome: -22103000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1487371/000148737115000029/gnmk-20141231.xml#212419 Filing: 000148737115000029 The citation records this snapshot. The page link may show a newer release later.	−USD 16.24 million Exact value Exact value: -16243000 USD 2012-01-01 – 2012-12-31: -16243000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · GenMark Diagnostics, Inc. · 2012-12-31 GenMark Diagnostics, Inc. (edgar:1487371) Operating Cash Flow: -16243000 USD Concept: fundies:OperatingCashFlow Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T17:14:31Z Snapshot: 4462fefe152a6b52ff9c984984a3a5ded6c7a77de6e1a618200eea0be81b76ca Dimensions: Consolidated View: https://fundies.io/companies/edgar/1487371/explain?concept=fundies%3AOperatingCashFlow&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -16243000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1487371/000148737115000029/gnmk-20141231.xml#211406 Filing: 000148737115000029 The citation records this snapshot. The page link may show a newer release later.	USD 3.48 million Exact value Exact value: 3476000 USD 2012-01-01 – 2012-12-31: 3476000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · GenMark Diagnostics, Inc. · 2012-12-31 GenMark Diagnostics, Inc. (edgar:1487371) Capital Expenditure: 3476000 USD Concept: fundies:CapitalExpenditure Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T17:14:31Z Snapshot: 4462fefe152a6b52ff9c984984a3a5ded6c7a77de6e1a618200eea0be81b76ca Dimensions: Consolidated View: https://fundies.io/companies/edgar/1487371/explain?concept=fundies%3ACapitalExpenditure&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 3476000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1487371/000148737115000029/gnmk-20141231.xml#226377 Filing: 000148737115000029 The citation records this snapshot. The page link may show a newer release later.	−USD 19.72 million Calculation and evidence -16243000 − 3476000 USD Exact free cash flow: -19719000 USD 2012-01-01 – 2012-12-31: -16243000 USD · Inspect Operating Cash Flow · Source 2012-01-01 – 2012-12-31: 3476000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · GenMark Diagnostics, Inc. · 2012-12-31 GenMark Diagnostics, Inc. (edgar:1487371) Free cash flow: -19719000 USD Concept: free-cash-flow Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T17:14:31Z Snapshot: 4462fefe152a6b52ff9c984984a3a5ded6c7a77de6e1a618200eea0be81b76ca Dimensions: Consolidated View: https://fundies.io/companies/edgar/1487371?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -16243000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1487371/000148737115000029/gnmk-20141231.xml#211406 Filing: 000148737115000029 Input fundies:CapitalExpenditure: 3476000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1487371/000148737115000029/gnmk-20141231.xml#226377 Filing: 000148737115000029 The citation records this snapshot. The page link may show a newer release later.
2014 2013-01-01 – 2013-12-31	−USD 33.64 million Exact value Exact value: -33643000 USD 2013-01-01 – 2013-12-31: -33643000 USD Inspect Net Income Open source Share or cite Citation for Net Income · GenMark Diagnostics, Inc. · 2013-12-31 GenMark Diagnostics, Inc. (edgar:1487371) Net Income: -33643000 USD Concept: fundies:NetIncome Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T17:14:31Z Snapshot: 4462fefe152a6b52ff9c984984a3a5ded6c7a77de6e1a618200eea0be81b76ca Dimensions: Consolidated View: https://fundies.io/companies/edgar/1487371/explain?concept=fundies%3ANetIncome&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:NetIncome: -33643000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1487371/000148737116000229/gnmk-20151231.xml#197758 Filing: 000148737116000229 The citation records this snapshot. The page link may show a newer release later.	−USD 23.8 million Exact value Exact value: -23796000 USD 2013-01-01 – 2013-12-31: -23796000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · GenMark Diagnostics, Inc. · 2013-12-31 GenMark Diagnostics, Inc. (edgar:1487371) Operating Cash Flow: -23796000 USD Concept: fundies:OperatingCashFlow Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T17:14:31Z Snapshot: 4462fefe152a6b52ff9c984984a3a5ded6c7a77de6e1a618200eea0be81b76ca Dimensions: Consolidated View: https://fundies.io/companies/edgar/1487371/explain?concept=fundies%3AOperatingCashFlow&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -23796000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1487371/000148737116000229/gnmk-20151231.xml#197122 Filing: 000148737116000229 The citation records this snapshot. The page link may show a newer release later.	USD 4.27 million Exact value Exact value: 4270000 USD 2013-01-01 – 2013-12-31: 4270000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · GenMark Diagnostics, Inc. · 2013-12-31 GenMark Diagnostics, Inc. (edgar:1487371) Capital Expenditure: 4270000 USD Concept: fundies:CapitalExpenditure Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T17:14:31Z Snapshot: 4462fefe152a6b52ff9c984984a3a5ded6c7a77de6e1a618200eea0be81b76ca Dimensions: Consolidated View: https://fundies.io/companies/edgar/1487371/explain?concept=fundies%3ACapitalExpenditure&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 4270000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1487371/000148737116000229/gnmk-20151231.xml#213858 Filing: 000148737116000229 The citation records this snapshot. The page link may show a newer release later.	−USD 28.07 million Calculation and evidence -23796000 − 4270000 USD Exact free cash flow: -28066000 USD 2013-01-01 – 2013-12-31: -23796000 USD · Inspect Operating Cash Flow · Source 2013-01-01 – 2013-12-31: 4270000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · GenMark Diagnostics, Inc. · 2013-12-31 GenMark Diagnostics, Inc. (edgar:1487371) Free cash flow: -28066000 USD Concept: free-cash-flow Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T17:14:31Z Snapshot: 4462fefe152a6b52ff9c984984a3a5ded6c7a77de6e1a618200eea0be81b76ca Dimensions: Consolidated View: https://fundies.io/companies/edgar/1487371?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -23796000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1487371/000148737116000229/gnmk-20151231.xml#197122 Filing: 000148737116000229 Input fundies:CapitalExpenditure: 4270000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1487371/000148737116000229/gnmk-20151231.xml#213858 Filing: 000148737116000229 The citation records this snapshot. The page link may show a newer release later.
2015 2014-01-01 – 2014-12-31	−USD 38.26 million Exact value Exact value: -38263000 USD 2014-01-01 – 2014-12-31: -38263000 USD Inspect Net Income Open source Share or cite Citation for Net Income · GenMark Diagnostics, Inc. · 2014-12-31 GenMark Diagnostics, Inc. (edgar:1487371) Net Income: -38263000 USD Concept: fundies:NetIncome Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T17:14:31Z Snapshot: 4462fefe152a6b52ff9c984984a3a5ded6c7a77de6e1a618200eea0be81b76ca Dimensions: Consolidated View: https://fundies.io/companies/edgar/1487371/explain?concept=fundies%3ANetIncome&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:NetIncome: -38263000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1487371/000148737117000062/gnmk-20161231.xml#211619 Filing: 000148737117000062 The citation records this snapshot. The page link may show a newer release later.	−USD 29.57 million Exact value Exact value: -29572000 USD 2014-01-01 – 2014-12-31: -29572000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · GenMark Diagnostics, Inc. · 2014-12-31 GenMark Diagnostics, Inc. (edgar:1487371) Operating Cash Flow: -29572000 USD Concept: fundies:OperatingCashFlow Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T17:14:31Z Snapshot: 4462fefe152a6b52ff9c984984a3a5ded6c7a77de6e1a618200eea0be81b76ca Dimensions: Consolidated View: https://fundies.io/companies/edgar/1487371/explain?concept=fundies%3AOperatingCashFlow&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -29572000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1487371/000148737117000062/gnmk-20161231.xml#210983 Filing: 000148737117000062 The citation records this snapshot. The page link may show a newer release later.	USD 5.73 million Exact value Exact value: 5726000 USD 2014-01-01 – 2014-12-31: 5726000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · GenMark Diagnostics, Inc. · 2014-12-31 GenMark Diagnostics, Inc. (edgar:1487371) Capital Expenditure: 5726000 USD Concept: fundies:CapitalExpenditure Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T17:14:31Z Snapshot: 4462fefe152a6b52ff9c984984a3a5ded6c7a77de6e1a618200eea0be81b76ca Dimensions: Consolidated View: https://fundies.io/companies/edgar/1487371/explain?concept=fundies%3ACapitalExpenditure&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 5726000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1487371/000148737117000062/gnmk-20161231.xml#227700 Filing: 000148737117000062 The citation records this snapshot. The page link may show a newer release later.	−USD 35.3 million Calculation and evidence -29572000 − 5726000 USD Exact free cash flow: -35298000 USD 2014-01-01 – 2014-12-31: -29572000 USD · Inspect Operating Cash Flow · Source 2014-01-01 – 2014-12-31: 5726000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · GenMark Diagnostics, Inc. · 2014-12-31 GenMark Diagnostics, Inc. (edgar:1487371) Free cash flow: -35298000 USD Concept: free-cash-flow Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T17:14:31Z Snapshot: 4462fefe152a6b52ff9c984984a3a5ded6c7a77de6e1a618200eea0be81b76ca Dimensions: Consolidated View: https://fundies.io/companies/edgar/1487371?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -29572000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1487371/000148737117000062/gnmk-20161231.xml#210983 Filing: 000148737117000062 Input fundies:CapitalExpenditure: 5726000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1487371/000148737117000062/gnmk-20161231.xml#227700 Filing: 000148737117000062 The citation records this snapshot. The page link may show a newer release later.
2016 2015-01-01 – 2015-12-31	−USD 42.2 million Exact value Exact value: -42197000 USD 2015-01-01 – 2015-12-31: -42197000 USD Inspect Net Income Open source Share or cite Citation for Net Income · GenMark Diagnostics, Inc. · 2015-12-31 GenMark Diagnostics, Inc. (edgar:1487371) Net Income: -42197000 USD Concept: fundies:NetIncome Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T17:14:31Z Snapshot: 4462fefe152a6b52ff9c984984a3a5ded6c7a77de6e1a618200eea0be81b76ca Dimensions: Consolidated View: https://fundies.io/companies/edgar/1487371/explain?concept=fundies%3ANetIncome&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:NetIncome: -42197000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1487371/000148737118000040/gnmk-20171231.xml#254318 Filing: 000148737118000040 The citation records this snapshot. The page link may show a newer release later.	−USD 31.92 million Exact value Exact value: -31915000 USD 2015-01-01 – 2015-12-31: -31915000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · GenMark Diagnostics, Inc. · 2015-12-31 GenMark Diagnostics, Inc. (edgar:1487371) Operating Cash Flow: -31915000 USD Concept: fundies:OperatingCashFlow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T17:14:31Z Snapshot: 4462fefe152a6b52ff9c984984a3a5ded6c7a77de6e1a618200eea0be81b76ca Dimensions: Consolidated View: https://fundies.io/companies/edgar/1487371/explain?concept=fundies%3AOperatingCashFlow&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -31915000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1487371/000148737118000040/gnmk-20171231.xml#253682 Filing: 000148737118000040 The citation records this snapshot. The page link may show a newer release later.	USD 3.76 million Exact value Exact value: 3756000 USD 2015-01-01 – 2015-12-31: 3756000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · GenMark Diagnostics, Inc. · 2015-12-31 GenMark Diagnostics, Inc. (edgar:1487371) Capital Expenditure: 3756000 USD Concept: fundies:CapitalExpenditure Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T17:14:31Z Snapshot: 4462fefe152a6b52ff9c984984a3a5ded6c7a77de6e1a618200eea0be81b76ca Dimensions: Consolidated View: https://fundies.io/companies/edgar/1487371/explain?concept=fundies%3ACapitalExpenditure&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 3756000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1487371/000148737118000040/gnmk-20171231.xml#275867 Filing: 000148737118000040 The citation records this snapshot. The page link may show a newer release later.	−USD 35.67 million Calculation and evidence -31915000 − 3756000 USD Exact free cash flow: -35671000 USD 2015-01-01 – 2015-12-31: -31915000 USD · Inspect Operating Cash Flow · Source 2015-01-01 – 2015-12-31: 3756000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · GenMark Diagnostics, Inc. · 2015-12-31 GenMark Diagnostics, Inc. (edgar:1487371) Free cash flow: -35671000 USD Concept: free-cash-flow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T17:14:31Z Snapshot: 4462fefe152a6b52ff9c984984a3a5ded6c7a77de6e1a618200eea0be81b76ca Dimensions: Consolidated View: https://fundies.io/companies/edgar/1487371?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -31915000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1487371/000148737118000040/gnmk-20171231.xml#253682 Filing: 000148737118000040 Input fundies:CapitalExpenditure: 3756000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1487371/000148737118000040/gnmk-20171231.xml#275867 Filing: 000148737118000040 The citation records this snapshot. The page link may show a newer release later.
2017 2016-01-01 – 2016-12-31	−USD 50.6 million Exact value Exact value: -50601000 USD 2016-01-01 – 2016-12-31: -50601000 USD Inspect Net Income Open source Share or cite Citation for Net Income · GenMark Diagnostics, Inc. · 2016-12-31 GenMark Diagnostics, Inc. (edgar:1487371) Net Income: -50601000 USD Concept: fundies:NetIncome Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T17:14:31Z Snapshot: 4462fefe152a6b52ff9c984984a3a5ded6c7a77de6e1a618200eea0be81b76ca Dimensions: Consolidated View: https://fundies.io/companies/edgar/1487371/explain?concept=fundies%3ANetIncome&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:NetIncome: -50601000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1487371/000148737119000055/gnmk-20181231.xml#249157 Filing: 000148737119000055 The citation records this snapshot. The page link may show a newer release later.	−USD 35.64 million Exact value Exact value: -35637000 USD 2016-01-01 – 2016-12-31: -35637000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · GenMark Diagnostics, Inc. · 2016-12-31 GenMark Diagnostics, Inc. (edgar:1487371) Operating Cash Flow: -35637000 USD Concept: fundies:OperatingCashFlow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T17:14:31Z Snapshot: 4462fefe152a6b52ff9c984984a3a5ded6c7a77de6e1a618200eea0be81b76ca Dimensions: Consolidated View: https://fundies.io/companies/edgar/1487371/explain?concept=fundies%3AOperatingCashFlow&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -35637000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1487371/000148737119000055/gnmk-20181231.xml#248521 Filing: 000148737119000055 The citation records this snapshot. The page link may show a newer release later.	USD 7 million Exact value Exact value: 7000000 USD 2016-01-01 – 2016-12-31: 7000000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · GenMark Diagnostics, Inc. · 2016-12-31 GenMark Diagnostics, Inc. (edgar:1487371) Capital Expenditure: 7000000 USD Concept: fundies:CapitalExpenditure Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T17:14:31Z Snapshot: 4462fefe152a6b52ff9c984984a3a5ded6c7a77de6e1a618200eea0be81b76ca Dimensions: Consolidated View: https://fundies.io/companies/edgar/1487371/explain?concept=fundies%3ACapitalExpenditure&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 7000000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1487371/000148737119000055/gnmk-20181231.xml#271179 Filing: 000148737119000055 The citation records this snapshot. The page link may show a newer release later.	−USD 42.64 million Calculation and evidence -35637000 − 7000000 USD Exact free cash flow: -42637000 USD 2016-01-01 – 2016-12-31: -35637000 USD · Inspect Operating Cash Flow · Source 2016-01-01 – 2016-12-31: 7000000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · GenMark Diagnostics, Inc. · 2016-12-31 GenMark Diagnostics, Inc. (edgar:1487371) Free cash flow: -42637000 USD Concept: free-cash-flow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T17:14:31Z Snapshot: 4462fefe152a6b52ff9c984984a3a5ded6c7a77de6e1a618200eea0be81b76ca Dimensions: Consolidated View: https://fundies.io/companies/edgar/1487371?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -35637000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1487371/000148737119000055/gnmk-20181231.xml#248521 Filing: 000148737119000055 Input fundies:CapitalExpenditure: 7000000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1487371/000148737119000055/gnmk-20181231.xml#271179 Filing: 000148737119000055 The citation records this snapshot. The page link may show a newer release later.
2018 2017-01-01 – 2017-12-31	−USD 61.85 million Exact value Exact value: -61850000 USD 2017-01-01 – 2017-12-31: -61850000 USD Inspect Net Income Open source Share or cite Citation for Net Income · GenMark Diagnostics, Inc. · 2017-12-31 GenMark Diagnostics, Inc. (edgar:1487371) Net Income: -61850000 USD Concept: fundies:NetIncome Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T17:14:31Z Snapshot: 4462fefe152a6b52ff9c984984a3a5ded6c7a77de6e1a618200eea0be81b76ca Dimensions: Consolidated View: https://fundies.io/companies/edgar/1487371/explain?concept=fundies%3ANetIncome&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:NetIncome: -61850000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1487371/000148737120000085/gnmk-20191231.xml#223463 Filing: 000148737120000085 The citation records this snapshot. The page link may show a newer release later.	−USD 53.42 million Exact value Exact value: -53422000 USD 2017-01-01 – 2017-12-31: -53422000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · GenMark Diagnostics, Inc. · 2017-12-31 GenMark Diagnostics, Inc. (edgar:1487371) Operating Cash Flow: -53422000 USD Concept: fundies:OperatingCashFlow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T17:14:31Z Snapshot: 4462fefe152a6b52ff9c984984a3a5ded6c7a77de6e1a618200eea0be81b76ca Dimensions: Consolidated View: https://fundies.io/companies/edgar/1487371/explain?concept=fundies%3AOperatingCashFlow&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -53422000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1487371/000148737120000085/gnmk-20191231.xml#222827 Filing: 000148737120000085 The citation records this snapshot. The page link may show a newer release later.	USD 4.82 million Exact value Exact value: 4815000 USD 2017-01-01 – 2017-12-31: 4815000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · GenMark Diagnostics, Inc. · 2017-12-31 GenMark Diagnostics, Inc. (edgar:1487371) Capital Expenditure: 4815000 USD Concept: fundies:CapitalExpenditure Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T17:14:31Z Snapshot: 4462fefe152a6b52ff9c984984a3a5ded6c7a77de6e1a618200eea0be81b76ca Dimensions: Consolidated View: https://fundies.io/companies/edgar/1487371/explain?concept=fundies%3ACapitalExpenditure&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 4815000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1487371/000148737120000085/gnmk-20191231.xml#240969 Filing: 000148737120000085 The citation records this snapshot. The page link may show a newer release later.	−USD 58.24 million Calculation and evidence -53422000 − 4815000 USD Exact free cash flow: -58237000 USD 2017-01-01 – 2017-12-31: -53422000 USD · Inspect Operating Cash Flow · Source 2017-01-01 – 2017-12-31: 4815000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · GenMark Diagnostics, Inc. · 2017-12-31 GenMark Diagnostics, Inc. (edgar:1487371) Free cash flow: -58237000 USD Concept: free-cash-flow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T17:14:31Z Snapshot: 4462fefe152a6b52ff9c984984a3a5ded6c7a77de6e1a618200eea0be81b76ca Dimensions: Consolidated View: https://fundies.io/companies/edgar/1487371?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -53422000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1487371/000148737120000085/gnmk-20191231.xml#222827 Filing: 000148737120000085 Input fundies:CapitalExpenditure: 4815000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1487371/000148737120000085/gnmk-20191231.xml#240969 Filing: 000148737120000085 The citation records this snapshot. The page link may show a newer release later.
2019 2018-01-01 – 2018-12-31	−USD 50.5 million Exact value Exact value: -50500000 USD 2018-01-01 – 2018-12-31: -50500000 USD Inspect Net Income Open source Share or cite Citation for Net Income · GenMark Diagnostics, Inc. · 2018-12-31 GenMark Diagnostics, Inc. (edgar:1487371) Net Income: -50500000 USD Concept: fundies:NetIncome Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T17:14:31Z Snapshot: 4462fefe152a6b52ff9c984984a3a5ded6c7a77de6e1a618200eea0be81b76ca Dimensions: Consolidated View: https://fundies.io/companies/edgar/1487371/explain?concept=fundies%3ANetIncome&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:NetIncome: -50500000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1487371/000148737121000096/gnmk-20201231.htm#910723 Filing: 000148737121000096 The citation records this snapshot. The page link may show a newer release later.	−USD 32.51 million Exact value Exact value: -32512000 USD 2018-01-01 – 2018-12-31: -32512000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · GenMark Diagnostics, Inc. · 2018-12-31 GenMark Diagnostics, Inc. (edgar:1487371) Operating Cash Flow: -32512000 USD Concept: fundies:OperatingCashFlow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T17:14:31Z Snapshot: 4462fefe152a6b52ff9c984984a3a5ded6c7a77de6e1a618200eea0be81b76ca Dimensions: Consolidated View: https://fundies.io/companies/edgar/1487371/explain?concept=fundies%3AOperatingCashFlow&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -32512000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1487371/000148737121000096/gnmk-20201231.htm#959843 Filing: 000148737121000096 The citation records this snapshot. The page link may show a newer release later.	USD 2.58 million Exact value Exact value: 2575000 USD 2018-01-01 – 2018-12-31: 2575000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · GenMark Diagnostics, Inc. · 2018-12-31 GenMark Diagnostics, Inc. (edgar:1487371) Capital Expenditure: 2575000 USD Concept: fundies:CapitalExpenditure Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T17:14:31Z Snapshot: 4462fefe152a6b52ff9c984984a3a5ded6c7a77de6e1a618200eea0be81b76ca Dimensions: Consolidated View: https://fundies.io/companies/edgar/1487371/explain?concept=fundies%3ACapitalExpenditure&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2575000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1487371/000148737121000096/gnmk-20201231.htm#964165 Filing: 000148737121000096 The citation records this snapshot. The page link may show a newer release later.	−USD 35.09 million Calculation and evidence -32512000 − 2575000 USD Exact free cash flow: -35087000 USD 2018-01-01 – 2018-12-31: -32512000 USD · Inspect Operating Cash Flow · Source 2018-01-01 – 2018-12-31: 2575000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · GenMark Diagnostics, Inc. · 2018-12-31 GenMark Diagnostics, Inc. (edgar:1487371) Free cash flow: -35087000 USD Concept: free-cash-flow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T17:14:31Z Snapshot: 4462fefe152a6b52ff9c984984a3a5ded6c7a77de6e1a618200eea0be81b76ca Dimensions: Consolidated View: https://fundies.io/companies/edgar/1487371?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -32512000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1487371/000148737121000096/gnmk-20201231.htm#959843 Filing: 000148737121000096 Input fundies:CapitalExpenditure: 2575000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1487371/000148737121000096/gnmk-20201231.htm#964165 Filing: 000148737121000096 The citation records this snapshot. The page link may show a newer release later.
2020 2019-01-01 – 2019-12-31	−USD 47.35 million Exact value Exact value: -47350000 USD 2019-01-01 – 2019-12-31: -47350000 USD Inspect Net Income Open source Share or cite Citation for Net Income · GenMark Diagnostics, Inc. · 2019-12-31 GenMark Diagnostics, Inc. (edgar:1487371) Net Income: -47350000 USD Concept: fundies:NetIncome Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T17:14:31Z Snapshot: 4462fefe152a6b52ff9c984984a3a5ded6c7a77de6e1a618200eea0be81b76ca Dimensions: Consolidated View: https://fundies.io/companies/edgar/1487371/explain?concept=fundies%3ANetIncome&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:NetIncome: -47350000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1487371/000148737121000096/gnmk-20201231.htm#909558 Filing: 000148737121000096 The citation records this snapshot. The page link may show a newer release later.	−USD 34.93 million Exact value Exact value: -34926000 USD 2019-01-01 – 2019-12-31: -34926000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · GenMark Diagnostics, Inc. · 2019-12-31 GenMark Diagnostics, Inc. (edgar:1487371) Operating Cash Flow: -34926000 USD Concept: fundies:OperatingCashFlow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T17:14:31Z Snapshot: 4462fefe152a6b52ff9c984984a3a5ded6c7a77de6e1a618200eea0be81b76ca Dimensions: Consolidated View: https://fundies.io/companies/edgar/1487371/explain?concept=fundies%3AOperatingCashFlow&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -34926000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1487371/000148737121000096/gnmk-20201231.htm#958795 Filing: 000148737121000096 The citation records this snapshot. The page link may show a newer release later.	USD 2.09 million Exact value Exact value: 2092000 USD 2019-01-01 – 2019-12-31: 2092000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · GenMark Diagnostics, Inc. · 2019-12-31 GenMark Diagnostics, Inc. (edgar:1487371) Capital Expenditure: 2092000 USD Concept: fundies:CapitalExpenditure Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T17:14:31Z Snapshot: 4462fefe152a6b52ff9c984984a3a5ded6c7a77de6e1a618200eea0be81b76ca Dimensions: Consolidated View: https://fundies.io/companies/edgar/1487371/explain?concept=fundies%3ACapitalExpenditure&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2092000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1487371/000148737121000096/gnmk-20201231.htm#963185 Filing: 000148737121000096 The citation records this snapshot. The page link may show a newer release later.	−USD 37.02 million Calculation and evidence -34926000 − 2092000 USD Exact free cash flow: -37018000 USD 2019-01-01 – 2019-12-31: -34926000 USD · Inspect Operating Cash Flow · Source 2019-01-01 – 2019-12-31: 2092000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · GenMark Diagnostics, Inc. · 2019-12-31 GenMark Diagnostics, Inc. (edgar:1487371) Free cash flow: -37018000 USD Concept: free-cash-flow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T17:14:31Z Snapshot: 4462fefe152a6b52ff9c984984a3a5ded6c7a77de6e1a618200eea0be81b76ca Dimensions: Consolidated View: https://fundies.io/companies/edgar/1487371?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -34926000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1487371/000148737121000096/gnmk-20201231.htm#958795 Filing: 000148737121000096 Input fundies:CapitalExpenditure: 2092000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1487371/000148737121000096/gnmk-20201231.htm#963185 Filing: 000148737121000096 The citation records this snapshot. The page link may show a newer release later.
2021 2020-01-01 – 2020-12-31	−USD 18.64 million Exact value Exact value: -18644000 USD 2020-01-01 – 2020-12-31: -18644000 USD Inspect Net Income Open source Share or cite Citation for Net Income · GenMark Diagnostics, Inc. · 2020-12-31 GenMark Diagnostics, Inc. (edgar:1487371) Net Income: -18644000 USD Concept: fundies:NetIncome Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T17:14:31Z Snapshot: 4462fefe152a6b52ff9c984984a3a5ded6c7a77de6e1a618200eea0be81b76ca Dimensions: Consolidated View: https://fundies.io/companies/edgar/1487371/explain?concept=fundies%3ANetIncome&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:NetIncome: -18644000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1487371/000148737121000096/gnmk-20201231.htm#908393 Filing: 000148737121000096 The citation records this snapshot. The page link may show a newer release later.	USD 6.13 million Exact value Exact value: 6134000 USD 2020-01-01 – 2020-12-31: 6134000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · GenMark Diagnostics, Inc. · 2020-12-31 GenMark Diagnostics, Inc. (edgar:1487371) Operating Cash Flow: 6134000 USD Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T17:14:31Z Snapshot: 4462fefe152a6b52ff9c984984a3a5ded6c7a77de6e1a618200eea0be81b76ca Dimensions: Consolidated View: https://fundies.io/companies/edgar/1487371/explain?concept=fundies%3AOperatingCashFlow&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 6134000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1487371/000148737121000096/gnmk-20201231.htm#957752 Filing: 000148737121000096 The citation records this snapshot. The page link may show a newer release later.	USD 17.78 million Exact value Exact value: 17776000 USD 2020-01-01 – 2020-12-31: 17776000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · GenMark Diagnostics, Inc. · 2020-12-31 GenMark Diagnostics, Inc. (edgar:1487371) Capital Expenditure: 17776000 USD Concept: fundies:CapitalExpenditure Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T17:14:31Z Snapshot: 4462fefe152a6b52ff9c984984a3a5ded6c7a77de6e1a618200eea0be81b76ca Dimensions: Consolidated View: https://fundies.io/companies/edgar/1487371/explain?concept=fundies%3ACapitalExpenditure&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 17776000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1487371/000148737121000096/gnmk-20201231.htm#962204 Filing: 000148737121000096 The citation records this snapshot. The page link may show a newer release later.	−USD 11.64 million Calculation and evidence 6134000 − 17776000 USD Exact free cash flow: -11642000 USD 2020-01-01 – 2020-12-31: 6134000 USD · Inspect Operating Cash Flow · Source 2020-01-01 – 2020-12-31: 17776000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · GenMark Diagnostics, Inc. · 2020-12-31 GenMark Diagnostics, Inc. (edgar:1487371) Free cash flow: -11642000 USD Concept: free-cash-flow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T17:14:31Z Snapshot: 4462fefe152a6b52ff9c984984a3a5ded6c7a77de6e1a618200eea0be81b76ca Dimensions: Consolidated View: https://fundies.io/companies/edgar/1487371?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 6134000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1487371/000148737121000096/gnmk-20201231.htm#957752 Filing: 000148737121000096 Input fundies:CapitalExpenditure: 17776000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1487371/000148737121000096/gnmk-20201231.htm#962204 Filing: 000148737121000096 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

58 filings · 3,763 latest values · 3,763 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001487371, 1487371, GNMK, edgar:1487371

Also known as GenMark Diagnostics, Inc.

GenMark Diagnostics, Inc.

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Reported share-count change

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2021 2020-01-01 – 2020-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation